Vaccine News and Research

Latest Vaccine News and Research

ACS Infectious Diseases journal highlights chemistry and collaborative research area

The American Chemical Society (ACS) announced today that Courtney Aldrich, Ph.D., will head the brand-new, web-only journal ACS Infectious Diseases as editor-in-chief. With the first issue slated for publication in January 2015, the pioneering journal will meet a growing demand for a place to publish top-notch chemistry-focused infectious diseases research.

11 Jul 2014

NIAID launches CRS3123 Phase I trial to treat C. difficile infection

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched an early-stage clinical trial of CRS3123, an investigational oral antibiotic intended to treat Clostridium difficile (C. difficile) infection.

10 Jul 2014

FDA approves Protein Sciences' strain change amendment for Flublok influenza vaccine

Protein Sciences Corporation announced today that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok.

9 Jul 2014

Study does not find association between HPV vaccination and increased risk of blood clot

Although some data has suggested a potential association between receipt of the quadrivalent human papillomavirus (HPV) vaccination and subsequent venous thromboembolism (VTE; blood clot), an analysis that included more than 500,000 women who received the vaccine did not find an increased risk of VTE, according to a study in the July 9 issue of JAMA.

8 Jul 2014

Viewpoints: Wheaton injunction muddies court's ruling on contraceptives; Boston hospital merger problems; advice for new VA chief

In a bizarre attempt to have it both ways, the Supreme Court held that a small evangelical Protestant college in Illinois did not have to include contraceptive coverage in employee health insurance even though it didn't fill out the paperwork the government required for claiming an exemption. ..

8 Jul 2014

Scientists uncover mechanisms that can protect against lethal bacteria

An important development in understanding how the bacterium that causes pneumonia, meningitis and septicaemia remains harmlessly in the nose and throat has been discovered at the University of Liverpool's Institute of Infection and Global Health.

8 Jul 2014

UC Riverside discovery could lead to future development of needle-free vaccines

Ripping a page from the Star Trek script, specialized cells of the barrier that lines the inside of the intestines and airways of humans have invoked a biological version of Captain Kirk's famous command "shields up" as a first defense against invading microbes.

8 Jul 2014

Survey shows biggest barrier to receiving Human Papillomavirus vaccine

A survey of first-year Grand Valley State University students showed the biggest barrier to receiving a Human Papillomavirus (HPV) vaccine was moral or religious beliefs, or a perceived promotion of sexual behavior, according to graduate physician assistant researchers.

8 Jul 2014

$FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL$

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).

7 Jul 2014

Penn’s immunotherapy receives FDA's Breakthrough Therapy designation for ALL treatment

A University of Pennsylvania-developed personalized immunotherapy has been awarded the U.S. Food and Drug Administration's Breakthrough Therapy designation for the treatment of relapsed and refractory adult and pediatric acute lymphoblastic leukemia (ALL).

7 Jul 2014

Research roundup: 20M gain insurance, coverage's effect on surgery choices; opioid use by service members

This report aims to help readers understand recently announced enrollment numbers, as well as other numbers that have received less attention, and assess their importance for the future of the ACA and our health care system. .

4 Jul 2014

Digital mammograms may not be better at diagnosing older women, study finds

The Yale review adds to the mixed report card on digital mammography, reports NPR. Meanwhile, big increases in vaccination prices are straining public health budgets and creating dilemmas for some doctors, finds The New York Times.

4 Jul 2014

First Edition: July 3,2014

Today's early morning highlights from the major news organizations, including more analysis of the Supreme Court's Hobby Lobby decision and concerns in New York about significant insurance rate increases for 2015.

3 Jul 2014

State highlights: Ore. mediation for medical errors; Mich. home-help aides

A mediation program spearheaded by Gov. John Kitzhaber went into effect Tuesday, giving patients and their families an option besides suing when medical errors happen. But questions remain over how the mediation program will develop, including whether hospitals, doctors and other providers will take advantage of the program, or candidly discuss errors if they do. The result of a compromise between trial lawyers and the Oregon Medical Association approved in SB 483 last year, the Early Discussion and Resolution program is intended to cut down on lawsuits and boost the reporting of medical errors to help improve health care practices (Budnick, 7/1).

3 Jul 2014

Clear advances in the fight against tuberculosis are within reach, say immunologists

Leading immunologists expect to see some clear advances in the fight against tuberculosis, an infectious disease that is widespread the world over. Professor Stefan Kaufmann, Director at the Max Planck Institute for Infection Biology in Berlin, echoed these sentiments at today's launch of the scientific programme for the 64th Lindau Nobel Laureate Meeting at Lindau, Germany.

2 Jul 2014

Viewpoints: Hobby Lobby decision celebrated and panned; gender and religious politics explored

In ruling 5 to 4 that "closely held" companies can refuse on religious grounds to include contraceptives in their employees' health plans, the Supreme Court has needlessly interfered with an important provision of the Affordable Care Act. And it has done more than that (7/1).

1 Jul 2014

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Agenus Inc., announced final results from a single-arm, multi-institutional, open-label, Phase 2 study showing that patients with newly diagnosed glioblastoma multiforme (GBM) who received Agenus' Prophage autologous cancer vaccine added to the standard of care treatment, lived nearly twice as long as expected.

1 Jul 2014

Viewpoints: Nothing in health care is free; Obamacare opponents lack facts; 'Nurse Jackie' and the ER

The Department of Health and Human Services released a report Friday declaring that 76 million Americans with private insurance became eligible for more preventive services with no out-of-pocket fees as a result of the 2010 healthcare law, the Patient Protection and Affordable Care Act (a.k.a. Obamacare). Because Democrats are counting on female voters to help them at the polls in November, the report highlighted how women had been helped by that aspect of Obamacare.

1 Jul 2014

Research shows foodborne pathogen can cause disease in some breeds of poultry

Contrary to popular belief, the foodborne pathogen Campylobacter jejuni is not a harmless commensal in chickens but can cause disease in some breeds of poultry according to research published in mBio-, the online open-access journal of the American Society for Microbiology.

1 Jul 2014

Host-directed therapy: A new type of TB treatment

In a new study published in Nature, scientists describe a new type of tuberculosis (TB) treatment that involves manipulating the body's response to TB bacteria rather than targeting the bacteria themselves, a concept called host-directed therapy.

28 Jun 2014

Vaccine News and Research

Latest Vaccine News and Research

ACS Infectious Diseases journal highlights chemistry and collaborative research area

NIAID launches CRS3123 Phase I trial to treat C. difficile infection

FDA approves Protein Sciences' strain change amendment for Flublok influenza vaccine

Study does not find association between HPV vaccination and increased risk of blood clot

Viewpoints: Wheaton injunction muddies court's ruling on contraceptives; Boston hospital merger problems; advice for new VA chief

Scientists uncover mechanisms that can protect against lethal bacteria

UC Riverside discovery could lead to future development of needle-free vaccines

Survey shows biggest barrier to receiving Human Papillomavirus vaccine

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Penn’s immunotherapy receives FDA's Breakthrough Therapy designation for ALL treatment

Research roundup: 20M gain insurance, coverage's effect on surgery choices; opioid use by service members

Digital mammograms may not be better at diagnosing older women, study finds

First Edition: July 3,2014

State highlights: Ore. mediation for medical errors; Mich. home-help aides

Clear advances in the fight against tuberculosis are within reach, say immunologists

Viewpoints: Hobby Lobby decision celebrated and panned; gender and religious politics explored

Prophage autologous cancer vaccine extends survival in patients with newly diagnosed GBM

Viewpoints: Nothing in health care is free; Obamacare opponents lack facts; 'Nurse Jackie' and the ER

Research shows foodborne pathogen can cause disease in some breeds of poultry

Host-directed therapy: A new type of TB treatment

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in